New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access. This story matters for General News readers tracking general. Reported by nytimes.com. Read the full original at the source link below.
Originally reported by nytimes.com. NewsDebate curates and briefs the general news stories that matter. Our editorial policy →